Novartis Investigative Site

Fatih / Istanbul, Turkey 34093

0 studies enrolling now · 1 studies all time

What they study most

Moderate to Severe Palmoplantar Psoriasis

Studies at this site

• Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis — Completed